Maternal Thrombophilia and Recurrent Miscarriage - Is There Evidence That Heparin is Indicated as Prophylaxis against Recurrence?

about

Maternal Thrombophilia and Recurrent Miscarriage - Is There Evidence That Heparin is Indicated as Prophylaxis against Recurrence?

Item

http://www.wikidata.org/entity/Q52806708

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Maternal Thrombophilia and Rec ...... rophylaxis against Recurrence?

@en

Maternal Thrombophilia and Rec ...... rophylaxis against Recurrence?

@nl

type

Item

label

Maternal Thrombophilia and Rec ...... rophylaxis against Recurrence?

@en

Maternal Thrombophilia and Rec ...... rophylaxis against Recurrence?

@nl

prefLabel

Maternal Thrombophilia and Rec ...... rophylaxis against Recurrence?

@en

Maternal Thrombophilia and Rec ...... rophylaxis against Recurrence?

@nl

P1476

Maternal Thrombophilia and Rec ...... rophylaxis against Recurrence?

@en

P2093

Ana-Luisa Stefanski

http://www.w3.org/2001/XMLSchema#string

Rebecca Fischer-Betz

http://www.w3.org/2001/XMLSchema#string

Thomas Dörner

http://www.w3.org/2001/XMLSchema#string

Wolfgang Henrich

http://www.w3.org/2001/XMLSchema#string

P2860

Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant

VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials.

Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients.

ALIFE2 study: low-molecular-weight heparin for women with recurrent miscarriage and inherited thrombophilia--study protocol for a randomized controlled trial

The association of factor V leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies.

EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome

Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomised trial.

Evaluation and treatment of recurrent pregnancy loss: a committee opinion.

P304

274-282

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1055/S-0044-100919

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

C Specker

Ekkehard Schleußner

P577

2018-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29576632

http://www.w3.org/2001/XMLSchema#string

P921

thrombophilia

miscarriage

P932

5862552

http://www.w3.org/2001/XMLSchema#string